当前位置: 首页 >> 检索结果
共有 20035 条符合本次的查询结果, 用时 2.4604418 秒

501. Heading for remission and its continuation in rheumatoid arthritis.

作者: Paul Studenic.
来源: Lancet Rheumatol. 2025年7卷4期e222-e224页

502. Utility of the GerdQ questionnaire in detecting gastroesophageal symptoms with RA patients.

作者: Yuji Nozaki.;Kazuya Kishimoto.;Daisuke Tomita.;Tetsu Itami.;Chisato Ashida.;Koji Kinoshita.;Itaru Matsumura.
来源: BMC Rheumatol. 2024年8卷1期73页
Rheumatoid arthritis (RA) affects multiple organ systems, including the esophagus. Moreover, one of the major side effects of methotrexate (MTX) is gastrointestinal disorders, which are said to affect medication adherence. We investigated the rate of MTX use, dosage, and the use of glucocorticoids (GCs) and oral non-steroidal anti-inflammatory drugs (NSAIDs) in relation to gastroesophageal (GE) symptoms, and whether they influence RA disease activity.

503. The association between composite dietary antioxidant index and rheumatoid arthritis: evidence from NHANES 2001-2020.

作者: Guangbin Ma.;Shulin Zhang.;Yiyan Luo.;Chengcheng Zhang.;Weina Xu.;Liyan Wang.
来源: BMC Rheumatol. 2024年8卷1期74页
This study aimed to investigate the relationship between the composite dietary antioxidant index (CDAI) and rheumatoid arthritis (RA) using data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2001 to 2020.

504. Precision weight management in people with knee osteoarthritis and overweight or obesity.

作者: Shiwen Yuan.;David J Hunter.
来源: Nat Rev Rheumatol. 2025年21卷3期129-130页

505. Protracted COVID-19 pneumonia in B-cell-depleted patients.

作者: Orhan Efe.;Gabriel Sauvage.;James Chung.;Anushya Jeyabalan.;Ayman Al Jurdi.;Harish S Seethapathy.;Karen A Laliberte.;John L Niles.
来源: Rheumatology (Oxford). 2025年64卷4期2303-2305页

506. Prescribing habits before and after regulation change: a British perspective.

作者: Ben Mulhearn.;Marwan Bukhari.
来源: Rheumatology (Oxford). 2025年64卷5期2341-2342页

507. Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.

作者: Noemie Chanson.;Alexandre Galvagni.;Manuel Ramos-Casals.;Juan Ignacio Ruiz.;Karijn Pm Suijkerbuijk.;Karolina Benesova.;Philippe Kerschen.;Jean Denis Karam.;Rakiba Belkhir.;Rodereau Outh.;Fabienne Closs-Prophette.;Jose Salvador Garcia Morillo.;Ángel Robles-Marhuenda.;Jean-Marie Michot.;Anne Laure Voisin.;Sabine Messayke.;Arianne Laparra.;Caroline Robert.;Maria Suarez-Almazor.;Xavier Mariette.;Olivier Lambotte.; .
来源: Rheumatology (Oxford). 2024年
To describe presentation, treatment and outcome of immune checkpoint inhibitor (ICI) associated-vasculitis in cancer patients in a multicentre study.

508. Withdrawn as duplicate: Transarterial periarticular embolization (TAPE) in checkpoint-inhibitor-associated arthritis-a novel treatment strategy.

作者: Andrew Moore.;Julia Bidonde.;Emma Fisher.;Winfried Häuser.;Rae Frances Bell.;Serge Perrot.;Souzi Makri.;Sebastian Straube.
来源: Rheumatology (Oxford). 2025年64卷3期1553-1560页
This article has been withdrawn due to an error that caused the article to be duplicated. The definitive version of this article is published under https://doi.org/10.1093/rheumatology/keae707.

509. Total-body positron emission tomography: a tool for systemic, quantitative evaluation of the inflammatory burden of psoriatic arthritis.

作者: Siba P Raychaudhuri.;Yasser G Abdelhafez.;Dario F Mazza.;Smriti K Raychaudhuri.;Simon R Cherry.;Lorenzo Nardo.;Ramsey D Badawi.;Abhijit J Chaudhari.
来源: Rheumatology (Oxford). 2024年
To test the hypothesis that recently-developed total body-positron emission tomography (TB-PET) imaging with integrated computed tomography (CT) will enable low-dose, quantitative, domain-specific evaluation of the total inflammatory burden of psoriatic arthritis (PsA), and associate with established outcome measures of the clinical domains of PsA.

510. Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data.

作者: Edoardo Cipolletta.;Georgina Nakafero.;Natalie McCormick.;Chio Yokose.;Anthony J Avery.;Mamas A Mamas.;Hyon K Choi.;Laila J Tata.;Abhishek Abhishek.
来源: Lancet Rheumatol. 2025年7卷3期e197-e207页
Initiating urate-lowering therapy can trigger gout flares. Gout flares have been associated with a temporally increased risk of cardiovascular events. Therefore, we aimed to estimate the risk of cardiovascular events in patients with gout initiating urate-lowering therapy with flare prophylaxis using colchicine (the drug recommended for gout flare prohphylaxis by many international societies) compared with no prophylaxis.

511. Beneficial side-effects of colchicine for patients with gout.

作者: Hein Janssens.;Matthijs Janssen.
来源: Lancet Rheumatol. 2025年7卷3期e151-e152页

512. Association between serum urate levels and all-cause mortality, cardiovascular and renal outcomes among gout patients in Singapore.

作者: Moses Yidong Lim.;Weixiang Lian.;Hwee Pin Phua.;Htet Lin Htun.;Kok Ooi Kong.;Ling Li Foo.;Teo Min-Li Claire.;Wei-Yen Lim.
来源: BMC Rheumatol. 2024年8卷1期71页
We investigated the longitudinal association between Serum Urate (SU) level and Acute Myocardial Infarction (AMI), Stroke, End Stage Renal Failure (ESRF) and all-cause mortality.

513. The role of C-reactive protein and genetic predisposition in the risk of psoriasis: results from a national prospective cohort.

作者: Huarun Li.;Haobin Zhang.;Xiangyue Zhao.;Jinping Huang.;Junguo Zhang.;Zhaoyan Liu.;Ju Wen.;Si Qin.
来源: BMC Rheumatol. 2024年8卷1期72页
Psoriasis is an immune-mediated chronic inflammatory disease associated with multiple factors. To evaluate the extent to which C-reactive protein (CRP) and genetic predisposition affect the incidence of psoriasis.

514. Abatacept for myositis.

作者: Sarah Onuora.
来源: Nat Rev Rheumatol. 2025年21卷2期65页

515. Molecular profiling for advancing precision rheumatology.

作者: Coziana Ciurtin.;Elizabeth C Jury.
来源: Nat Rev Rheumatol. 2025年21卷2期73-74页

516. Blocking CDK7 attenuates inflammatory arthritis.

作者: Sarah Onuora.
来源: Nat Rev Rheumatol. 2025年21卷2期65页

517. Synovial dendritic cell subsets in RA.

作者: Maria Papatriantafyllou.
来源: Nat Rev Rheumatol. 2025年21卷2期66页

518. European expert recommendations for managing systemic sclerosis and its complications.

作者: Robyn T Domsic.
来源: Nat Rev Rheumatol. 2025年21卷3期133-134页

519. Insights into IVDD pathogenesis in 2024.

作者: Daisuke Sakai.
来源: Nat Rev Rheumatol. 2025年21卷2期71-72页

520. Promise and challenges of mesenchymal stromal cell therapy in severe SLE.

作者: Ioannis Parodis.
来源: Lancet Rheumatol. 2025年7卷4期e224-e226页
共有 20035 条符合本次的查询结果, 用时 2.4604418 秒